Valuation: Proto Script Pharmaceutical Corp.

Market Cap 1.97M 1.75M 1.62M 1.48M 2.77M 186M 2.81M 19.47M 7.66M 97.4M 7.37M 7.22M 311M P/E 2015 *
-
P/E 2016 -41.4x
Enterprise Value 2.01M 1.79M 1.66M 1.51M 2.84M 191M 2.88M 19.94M 7.84M 99.77M 7.55M 7.4M 319M EV / Sales 2015 *
-
EV / Sales 2016 394x
Free-Float
89.82%
Yield 2015 *
-
Yield 2016 -
Current year 0
Extreme 0.0001
0
1 year 0
Extreme 0.0001
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
2.2
Manager TitleAgeSince
Chief Executive Officer 58 29/06/2016
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-66.67%-98.00% 5.69K
+0.08%+3.51%+16.99%+72.33% 739B
-0.65%+3.44%+10.38%+68.89% 84.85B
-0.45%-3.02%+2.47%+149.28% 64.09B
-0.34%+0.82%-18.34%+3.10% 48.5B
-0.50%+0.89%+1.31%+75.46% 47.09B
+2.88%-18.96%+56.18%+751.20% 45.36B
-0.30%+0.30%+5.26%+29.40% 31.15B
+0.68%+1.23%+40.73%+66.37% 26.25B
+0.29%+3.56%-61.58%-57.41% 25.29B
Average +0.24%-0.89%-1.33%+106.06% 111.16B
Weighted average by Cap. +0.10%+2.48%+13.49%+97.02%

Financials

2015 2016
Net sales 881K 786K 728K 662K 1.24M 83.57M 1.26M 8.73M 3.43M 43.68M 3.31M 3.24M 140M 789K 703K 651K 592K 1.11M 74.8M 1.13M 7.81M 3.07M 39.1M 2.96M 2.9M 125M
Net income -145K -129K -120K -109K -205K -13.77M -208K -1.44M -566K -7.2M -545K -534K -23.01M -7.18M -6.4M -5.93M -5.39M -10.12M -681M -10.29M -71.14M -27.97M -356M -26.95M -26.39M -1.14B
Net Debt 27.07K 24.13K 22.35K 20.32K 38.14K 2.57M 38.76K 268K 105K 1.34M 102K 99.44K 4.29M 47.78K 42.59K 39.46K 35.87K 67.32K 4.53M 68.43K 473K 186K 2.37M 179K 176K 7.57M
Logo Proto Script Pharmaceutical Corp.
Proto-Script Pharmaceuticals, Corp., formerly Yanex Group, Inc. is a development-stage company. The Company is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The Company has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The Company's health care insurance contracts allow it the ability to service patients nationally. The Company intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The Company currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Employees
13
  1. Stock Market
  2. Stocks
  3. PSCR Stock